Home/Filings/4/0000805928-25-000132
4//SEC Filing

Burke William P. Mr. 4

Accession 0000805928-25-000132

CIK 0000805928other

Filed

Oct 30, 8:00 PM ET

Accepted

Oct 31, 4:09 PM ET

Size

19.8 KB

Accession

0000805928-25-000132

Insider Transaction Report

Form 4
Period: 2025-10-29
Transactions
  • Exercise/Conversion

    Stock Option (right to purchase)

    2025-10-2919,79939,596 total
    Exercise: $8.14Exp: 2032-07-11Common Stock (19,799 underlying)
  • Sale

    Common Stock

    2025-10-29$22.00/sh19,799$435,578100 total
  • Exercise/Conversion

    Common Stock

    2025-10-30$7.04/sh+18,248$128,46618,348 total
  • Exercise/Conversion

    Employee Stock Option (right to purchase)

    2025-10-3018,2480 total
    Exercise: $7.04Exp: 2034-06-06Common Stock (18,248 underlying)
  • Exercise/Conversion

    Common Stock

    2025-10-29$6.30/sh+20,436$128,74720,536 total
  • Sale

    Common Stock

    2025-10-29$19.15/sh20,436$391,435100 total
  • Exercise/Conversion

    Common Stock

    2025-10-29$8.14/sh+19,799$161,16419,899 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-10-2920,4360 total
    Exercise: $6.30Exp: 2033-09-01Common Stock (20,436 underlying)
  • Sale

    Common Stock

    2025-10-30$23.00/sh18,248$419,704100 total
Footnotes (5)
  • [F1]The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.50 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F2]The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025.
  • [F3]This grant vested on the first anniversary of the date of the grant, September 1, 2023.
  • [F4]This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022.
  • [F5]This grant vested on the first anniversary of the date of the grant, June 6, 2024.

Issuer

Axogen, Inc.

CIK 0000805928

Entity typeother

Related Parties

1
  • filerCIK 0001682069

Filing Metadata

Form type
4
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:09 PM ET
Size
19.8 KB